US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
AbstractThe report covers forecast and analysis for the active implantable medical devices market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the active implantable medical devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active implantable medical devices market on a global level. In order to give the users of this report a comprehensive view of the active implantable medical devices market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type and regional expansion of major participants involved in the market. The study provides a decisive view of the active implantable medical devices market by segmenting it into the product, application, end user and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecasts demand North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorized into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for active implantable medical devices market based on all segments in all the regions and countries. The key players in the global active implantable medical devices market are Abbott Laboratories, Boston Scientific Corp., Cochlear Ltd., LivaNova Plc., Medtronic Plc, Sonova Holding AG, Nurotron Biotechnology Co.Ltd., William Demant Holding A/S, BIOTRONIK SE, and MED-EL. This report segments the global active implantable medical devices market as follows: Global Active Implantable Medical Devices Market: Product Segment Analysis Cardiac Pacemakers Single Chamber Pacemakers Dual Chamber Pacemakers Others Implantable Cardioventer Defibrillators (ICD) Transvenous ICD Subcutaneous ICD Nerve Simulators Spinal Cord Simulators Deep Brain Simulators Sacral Nerve Simulators Vagus Nerve Simulators Gastric Electrical Simulators Cochlear Implants Ventricular Assist Devices Global Active Implantable Medical Devices Market: Application Segment Analysis Cardiovascular Neurological Hearing impairment Others Global Active Implantable Medical Devices Market: End-User Segment Analysis Hospitals Specialty Clinics Ambulatory Surgical Centers Global Active Implantable Medical Devices Market: Regional Segment Analysis North America The U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa
Table of Contents Request Table Of Content Click To Request Sample Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global active implantable medical devices market, 2015 - 2024 (USD Billion) 2.2. Global active implantable medical devices mark | read more...